TETTAMANTI, SARAH
 Distribuzione geografica
Continente #
NA - Nord America 1.717
EU - Europa 1.108
AS - Asia 477
SA - Sud America 9
AF - Africa 4
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.320
Nazione #
US - Stati Uniti d'America 1.700
IT - Italia 426
IE - Irlanda 195
SG - Singapore 162
CN - Cina 156
DE - Germania 146
SE - Svezia 109
RU - Federazione Russa 78
HK - Hong Kong 51
GB - Regno Unito 42
IN - India 35
FI - Finlandia 18
CA - Canada 17
UA - Ucraina 15
BE - Belgio 14
ID - Indonesia 14
PK - Pakistan 13
DK - Danimarca 12
VN - Vietnam 12
JP - Giappone 10
FR - Francia 9
RO - Romania 8
NL - Olanda 7
AT - Austria 6
TR - Turchia 6
TW - Taiwan 5
AU - Australia 4
BR - Brasile 4
CH - Svizzera 4
NO - Norvegia 4
RS - Serbia 4
CZ - Repubblica Ceca 3
ES - Italia 3
IR - Iran 3
KR - Corea 3
BD - Bangladesh 2
BO - Bolivia 2
EG - Egitto 2
IL - Israele 2
LT - Lituania 2
PE - Perù 2
PL - Polonia 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
CO - Colombia 1
MA - Marocco 1
MY - Malesia 1
ZA - Sudafrica 1
Totale 3.320
Città #
Ann Arbor 429
Chandler 196
Dublin 189
Singapore 144
Milan 126
Fairfield 114
Frankfurt am Main 106
Ashburn 96
Wilmington 78
Seattle 74
Woodbridge 62
New York 58
Houston 51
Hong Kong 49
Cambridge 47
Shanghai 47
Santa Clara 42
Princeton 39
Bergamo 36
Dearborn 28
Lissone 22
Nanjing 21
Altamura 17
Brussels 14
Jakarta 14
Lawrence 14
Monza 13
Borgomanero 12
Carrboro 11
Jacksonville 11
Carate Brianza 10
Dallas 10
Helsinki 10
Hyderabad 10
Chicago 9
Andover 8
Fremont 8
Galliate 8
Rome 8
Tokyo 8
Hangzhou 7
London 7
Munich 7
Beijing 6
Lahore 6
Missaglia 6
Cinisello Balsamo 5
Contursi 5
Edmonton 5
Islamabad 5
Jinan 5
Lappeenranta 5
Naples 5
Ottawa 5
Pioltello 5
Pune 5
Toronto 5
Turin 5
Vienna 5
Bologna 4
Caronno Pertusella 4
Genoa 4
San Diego 4
Zhengzhou 4
Amstelveen 3
Bergen 3
Boardman 3
Brescia 3
Brno 3
Castano Primo 3
Cerreto Guidi 3
Changsha 3
Delhi 3
Desio 3
Durham 3
Florence 3
Guangzhou 3
Kocaeli 3
Kunming 3
Legnano 3
Manchester 3
Muggiò 3
Mumbai 3
Nanchang 3
New Taipei 3
Pavia 3
Perugia 3
Stockholm 3
Torino 3
Washington 3
Bari 2
Borca 2
Boston 2
Bucharest 2
Carate 2
Catania 2
Charlottesville 2
Chengdu 2
Dhaka 2
Dong Ket 2
Totale 2.471
Nome #
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies 292
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 264
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 243
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia 241
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 236
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia 229
Transposon-Based CAR T Cells in Acute Leukemias: Where are We Going? 198
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA 148
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia 132
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 131
Combining the Expression of CD33.CAR and CXCR4 to Increase CAR-CIK Cell Homing to Bone Marrow Niche and Leukemic Stem Cell Eradication in Acute Myeloid Leukemia 120
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 118
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden 111
Catch me if you can: how AML and its niche escape immunotherapy 102
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use 100
Cellule CD33.CAR-CIK ingegnerizzate per co-esprimere il recettore CXCR4 al fine di aumentare la capacità di migrazione all’interno della nicchia midollare nella leucemia mieloide acuta 98
Generation of CIK cells co-expressing CXCR4 and CD33.CAR with improved homing and antitumor activity for AML 94
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden 84
CXCR4-modified CD33.CAR-CIK with enhanced bone marrow homing in Acute Myeloid Leukemia 84
Combining the expression of CD33.CAR and CXCR4 to augment CAR-CIKs homing to bone marrow niche and leukemic stem cell eradication in acute myeloid leukemia 83
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche 61
CARs are sharpening their weapons 61
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML 59
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia 58
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare 48
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia 48
Acute Myeloid Leukemia (AML) immunotherapy: development of TIM3-CD33 targeted Dual CAR CIK cells for eradication of LSCs in the bone marrow niche 38
Totale 3.481
Categoria #
all - tutte 13.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020207 0 0 0 0 30 44 48 20 20 11 12 22
2020/2021627 20 72 136 55 51 62 39 46 33 43 29 41
2021/2022340 23 33 22 18 20 18 11 15 24 32 24 100
2022/2023737 102 174 70 66 17 97 19 53 51 4 60 24
2023/2024747 32 30 45 61 72 181 123 47 61 19 14 62
2024/2025485 65 111 148 66 95 0 0 0 0 0 0 0
Totale 3.481